Seroepidemiology of pertussis in Hangzhou, China, during 2009–2017

References

• Hamborsky J, Kroger A, Wolfe S. Epidemiology and prevention of vaccine-preventable diseases (the pink book). Washington (DC): Public Health Foundation; 2015.
   Google Scholar
• WHO.Immunization surveillance, assessment and monitoring [EB/OL]. (2008) [2010]. http://www.Wuo.int/immunization-monitoring/diseases/pertussis/en.
   Google Scholar
• Zhang Q, Zheng H, Liu M,Han K, Shu J, Wu C, Xu N, He Q, Luo H. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis. 2012;12:138. doi:10.1186/1471-2334-12-166.
   PubMed Web of Science ®Google Scholar
• Winter K, Glaser C, Watt J, Harriman K; Centers for Disease C, Prevention. Pertussis epidemic–california, 2014. MMWR Morb Mortal Wkly Rep. 2014;63(48):1129–32.
   PubMed Web of Science ®Google Scholar
• CHEN Tao, XIE Na, FUERHATI W,Epidemiology of pertussis in Xinjiang uyghur autonomous region, 2004–2012 [J]. Dis Surveillance. 2013;28(11):911–13. (In Chinese).
   Google Scholar
• Huang H. Research progress on re-emergence of pertussis and its control strategy [J]. Med Recapitulate. 2015;21(9):1630–32. (in Chinese)
   Google Scholar
• Hu W, Zhang S. Epidemiological characteristic of pertussis and sero-epidemiology investigation of the population in Shanxi Province, 2006–2015 [J]. Mod Prev Med. 2017;44(1):163–66. (In Chinese)
   Google Scholar
• Williamson YM, Moura H, Whitmon J, Woolfitt AR, Schieltz DM, Rees JC, Guo S, Kirkham H, Bouck D, Ades EW, et al. A proteomic characterization of Bordetella pertussis clinical isolates associated with a California State pertussis outbreak. Int J Proteomics. 2015;2015:536537. doi:10.1155/2015/647408.
   PubMedGoogle Scholar
• Paradowska-Stankiewicz I, Rudowska J. Pertussis in Poland in 2012. Przegl Epidemiol. 2014;68:205–07.
   PubMedGoogle Scholar
• Shamsizadeh A, Nikfar R, Yusefi H, Abbasi-Montazeri E, Cheraghian B. Seroprevalence of pertussis antibodies in 6–17-year-old students in Ahvaz, south-west Islamic Republic of Iran. East Mediterr Health J. 2014;20(10):623–26.
   PubMed Web of Science ®Google Scholar
• ZHANG Ying, HUANG Hai-Tao, LIU Yong, et al. Incidence surveillance of pertussis based on community and analysis of its transmitted features in Tianjin [J]. Chinese J Vaccines Immunization. 2011;17(3):209–12. (In Chinese).
   Google Scholar
• Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium. Epidemiol Infect. 2011;139(4):494–504. doi:10.1017/S0950268810001536.
   PubMed Web of Science ®Google Scholar
• Liu Q, Feng D, Zhao S, et al. Antibody levels of pertussis, diphtheria and tetanus in healthy population in Henan province [J]. Contemp Med. 2013;19(31):160–61. (In Chinese).
   Google Scholar
• Su F, Ge B, Liang F, et al. Monitoring the immunity level of diphtheria in healthy population in Jiangyin city,in 2011[J]. J Med Pest Control. 2012;28(9):1047–48. (In Chinese).
   Google Scholar
• Liu G, Lu Z, Lin Y, et al. Antibody level and epidemiological character of pertussis in Shenzhen from 2010 to 2013 [J]. Prog Microbiol Immunol. 2015;43(4):40–43. (In Chinese).
   Google Scholar
• Zhan J, Huo X, Yang B, et al. Surveillance on immuning levels against pertussis, diphtheria and tetanus among healthy population in some areas of Hubei Province in 2010 [J]. Practi Prev Med. 2011;18(9):1647–49. (In Chinese).
   Google Scholar
• Wu A, Guo B, Chen M, et al. Detection and analysis of antibody level of pertussis in healthy population [J]. Zhejiang Preventive Med. 2013;25(6):35–36. (In Chinese).
   Google Scholar
• Lang PO, Govind S, Michel JP, Aspinall R, Mitchell WA. Immunosenescence: implications for vaccination programmes in adults. Maturitas. 2011;68(4):322–30. doi:10.1016/j.maturitas.2011.01.011.
   PubMed Web of Science ®Google Scholar
• Liu XL, Wang YJ, Li GP, et al. Serological surveillance on antibody levels to pertussis, diphtheria and tetanus among healthy people in Tongchuan [J]. Dis Surveillance. 2012;27(7):516–19. (In Chinese).
   Google Scholar
• Saul N, Wang K, Bag S, Baldwin H, Alexander K, Chandra M, Thomas J, Quinn H, Sheppeard V, Conaty S. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: the NSW public health network case-control study. Vaccine. 2018;36(14):1887–92. doi:10.1016/j.vaccine.2018.02.047.
   PubMed Web of Science ®Google Scholar
• Dabrera G, Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Fry NK, Ramsay M. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013. Clin Infect Dis. 2015;60(3):333–37. doi:10.1093/cid/ciu821.
   PubMed Web of Science ®Google Scholar
• Australian Technical Advisory Group on Immunisation (ATAGI). The Australian immunisation handbook. 10th ( (2015 update)). Canberra, Australia: Australian Government Department of Health; 2015.
   Google Scholar
• Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367(11):1012–19. doi:10.1056/NEJMoa1200850.
   PubMed Web of Science ®Google Scholar
• Cevik M, Beyazova U, Aral AL, Camurdand AD, Camurdan AD, Ozkane S, Sahinb F, Aybay C. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4–24 years in Turkey. Clin Microbiol Infect. 2008;14(4):388–90. doi:10.1111/j.1469-0691.2007.01926.x.
   PubMed Web of Science ®Google Scholar
• Who. Pertussis vaccines: WHO position paper, August 2015–recommendations. Vaccine. 2016;34(12):1423–25. doi:10.1016/j.vaccine.2015.10.136.
   PubMed Web of Science ®Google Scholar
• Wang Q, Sun M, Shi S. Analysis of diphtheria antibody level in healthy population in Xicheng district of Beijing. Capital J Public Health. 2013;7(5):226–28. (In Chinese)
   Google Scholar
• Glanz JM, Narwaney KJ, Newcomer SR, Daley MF, Hambidge SJ, Rowhani-Rahbar A, Lee GM, Nelson JC, Naleway AL, Nordin JD, et al. Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age. JAMA Pediatr. 2013;167(11):1060–64. doi:10.1001/jamapediatrics.2013.2353.
   PubMed Web of Science ®Google Scholar
• Atwell JE, Van Otterloo J, Zipprich J, Winter K, Harriman K, Salmon DA, Halsey NA, Omer SB. Nonmedical vaccine exemptions and pertussis in California, 2010. Pediatrics. 2013;132(4):624–30. doi:10.1542/peds.2013-0878.
   PubMed Web of Science ®Google Scholar
• Wu J, Chen Q, Zhang W. Antibody levels of pertussis, diphtheria and tetanus in healthy population in Shaoguan city [J]. South China J Prev Med. 2006;32(4):45–46. (In Chinese)
   Google Scholar
• Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis. 2012;54(12):1730–35. doi:10.1093/cid/cis287.
   PubMed Web of Science ®Google Scholar
• Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA. 2012;308(5):454–56. doi:10.1001/jama.2012.6364.
   PubMed Web of Science ®Google Scholar
• Jongerius I, Schuijt TJ, Mooi FR, Pinelli E. Complement evasion by Bordetella pertussis: implications for improving current vaccines. J Mol Med (Berl). 2015;93(4):395–402. doi:10.1007/s00109-015-1259-1.
   PubMed Web of Science ®Google Scholar
• Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med. 2015;13:146. doi:10.1186/s12916-015-0382-8.
   PubMed Web of Science ®Google Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A. 2014;111(2):787–92. doi:10.1073/pnas.1314688110.
   PubMed Web of Science ®Google Scholar
• Higgs R, Higgins SC, Ross PJ, Mills KH. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol. 2012;5(5):485–500. doi:10.1038/mi.2012.54.
   PubMed Web of Science ®Google Scholar
• Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K,, Misiak A, Lavelle EC, McLoughlin RM, Mills KH. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog. 2013;9(4):e1003264. doi:10.1371/journal.ppat.1003264.
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines for pertussis vaccine selection (revised)[J]. Int J Biol. 2015;38(1):46–47.
   Google Scholar
• Kazunar I, Kamachi K. DNA vaccine encoding pertussis toxin S1 Subuntinduces protection against Bordetella pertussis in mice [J]. Vaccine. 2003;21(31):4609. doi:10.1016/S0264-410X(03)00441-9.
   PubMed Web of Science ®Google Scholar
• Huang L, Xu E, Yang L, et al. Observation of immunity level of pertussis-diphtheria-tetanus in healthy people in Hangzhou City during 1995–2006. Chinese J Vaccines Immunization. 2009;15(1):68–71. (In Chinese).
   Google Scholar